Pre-transplant phase angle as a potential marker for predicting the development of infection after allogeneic hematopoietic stem cell transplantation

被引:2
作者
Hamada, Ryota [1 ,4 ]
Murao, Masanobu [1 ]
Asano, Tsugumi [1 ]
Miyasaka, Junsuke [1 ]
Matsushita, Michiko [1 ]
Kajimoto, Taishi [1 ]
Otagaki, Ayumi [1 ]
Nankaku, Manabu [1 ]
Kobayashi, Ami [2 ]
Kondo, Tadakazu [3 ]
Arai, Yasuyuki [3 ]
Kanda, Junya [3 ]
Takaori-Kondo, Akifumi [3 ]
Ikeguchi, Ryosuke [1 ]
Matsuda, Shuichi [1 ]
机构
[1] Kyoto Univ Hosp, Dept Rehabil, 54 Shogoin Kawahara cho, Sakyo ku, Kyoto 6068507, Japan
[2] Kyoto Univ Hosp, Dept Metab & Clin Nutr, 54 Shogoin Kawahara cho, Sakyo ku, Kyoto 6068507, Japan
[3] Kyoto Univ, Grad Sch Med, Dept Hematol & Oncol, 54 Kawahara cho, Sakyo ku, Kyoto 6068507, Japan
[4] Kyoto Univ Hosp, Rehabil Unit, 54 Shogoin Kawahara Cho,Sakyo Ku, Kyoto 6068507, Japan
关键词
Allogeneic hematopoietic stem cell transplantation; Phase angle; Appendicular skeletal muscle mass; Infection; BIOELECTRICAL-IMPEDANCE ANALYSIS; PREEMPTIVE THERAPY; CLINICAL-PRACTICE; DISEASES SOCIETY; 2016; UPDATE; MASS INDEX; IMPACT; DEFINITIONS; GUIDELINES; MANAGEMENT;
D O I
10.1016/j.clnesp.2023.09.925
中图分类号
R15 [营养卫生、食品卫生]; TS201 [基础科学];
学科分类号
100403 ;
摘要
Background & aims: Nutritional assessment in allogeneic hematopoietic stem cell transplantation (allo-HSCT) is important and decreased skeletal muscle mass is a risk factor for the development of infection. Recently, it has become clear that qualitative rather than skeletal muscle mass loss is a marker that reflects post-transplant outcome, but its association with the development of infection remains unclear. Therefore, we assessed skeletal muscle status by body composition using bioelectrical impedance analysis (BIA) and investigated its association with the development of infection.Methods: A retrospective cohort study was conducted to assess the quantity as well as quality of skeletal muscle using the body composition of BIA assessment. The quantitative (appendicular skeletal muscle mass index; ASM) and qualitative (phase angle; PhA) indicators of skeletal muscle calculated from body composition analysis were used to determine factors influencing the development of infection after allo-HSCT.Results: In total, 80 adult patients, aged 20-70 years (median, 52) were included in this study. The ASM was mildly decreased after allo-HSCT and PhA was significantly decreased. Furthermore, low pre-transplant PhA was identified as an independent risk factor for the development of infection early after transplantation, with a cutoff value of 4.9(degrees).Conclusion: In particular, pre-transplant PhA may predict the development of infection early after allo-HSCT, and muscle indices that can be assessed with pre-transplant body composition are a useful evaluation method that can discriminate post-transplant outcomes.(c) 2023 European Society for Clinical Nutrition and Metabolism. Published by Elsevier Ltd. All rights reserved.
引用
收藏
页码:122 / 127
页数:6
相关论文
共 50 条
  • [31] Allogeneic hematopoietic stem cell transplantation and pre-transplant strategies in patients with NPM1-mutated acute myeloid leukemia: a single center experience
    Jaeger, Paul
    Rautenberg, Christina
    Kaivers, Jennifer
    Kasprzak, Annika
    Geyh, Stefanie
    Baermann, Ben-Niklas
    Haas, Rainer
    Germing, Ulrich
    Schroeder, Thomas
    Kobbe, Guido
    SCIENTIFIC REPORTS, 2023, 13 (01)
  • [32] Impact of Pre-Transplant Anti-T Cell Globulin (ATG) on Immune Recovery after Myeloablative Allogeneic Peripheral Blood Stem Cell Transplantation
    Servais, Sophie
    Menten-Dedoyart, Catherine
    Beguin, Yves
    Seidel, Laurence
    Gothot, Andre
    Daulne, Coline
    Willems, Evelyne
    Delens, Loic
    Humblet-Baron, Stephanie
    Hannon, Muriel
    Baron, Frederic
    PLOS ONE, 2015, 10 (06):
  • [33] Immune Reconstitutional after Allogeneic Hematopoietic Stem Cell Transplantation
    Ogonek, Justyna
    Juric, Mateja Kralj
    Ghimire, Sakhila
    Varanasi, Pavankumar Reddy
    Holler, Ernst
    Greinix, Hildegard
    Weissinger, Eva
    FRONTIERS IN IMMUNOLOGY, 2016, 7
  • [34] Toxoplasmic encephalitis after allogeneic hematopoietic stem cell transplantation
    Cetinkaya, Feyza Izci
    Mumcu, Necati
    Unuvar, Gamze Kalin
    Kilic, Aysegul Ulu
    Kaynar, Leylagul
    NORTHERN CLINICS OF ISTANBUL, 2022, 9 (03) : 282 - 285
  • [35] Management of dyslipidemia after allogeneic hematopoietic stem cell transplantation
    Lu, Yingxue
    Ma, Xiaojing
    Pan, Jie
    Ma, Rongqiang
    Jiang, Yujie
    LIPIDS IN HEALTH AND DISEASE, 2022, 21 (01)
  • [36] Epileptic Seizures After Allogeneic Hematopoietic Stem Cell Transplantation
    Wang, Zhuo
    Zhao, Munan
    Gao, Sujun
    FRONTIERS IN NEUROLOGY, 2021, 12
  • [37] Disseminated fusarium infection after allogeneic hematopoietic stem cell transplantation after CART A case report
    Fei, Hairong
    Liu, Xiaodan
    Sun, Lingjie
    Shi, Xue
    Wang, Wei
    Zhao, Hongguo
    Zhao, Chunting
    MEDICINE, 2022, 101 (45) : E31594
  • [38] The potential role of pre-transplant HBcIgG seroposivity as predictor of clinically relevant cytomegalovirus infection in patients with lymphoma undergoing autologous hematopoietic stem cell transplantation: A study from the Rome Transplant Network
    Marchesi, Francesco
    Giannotti, Federica
    Avvisati, Giuseppe
    Petti, Maria Concetta
    Pimpinelli, Fulvia
    Paba, Pierpaolo
    Dessanti, Maria Laura
    Cerretti, Raffaella
    Tirindelli, Maria Cristina
    Picardi, Alessandra
    D'Andrea, Mariella
    Spadea, Antonio
    Ensoli, Fabrizio
    Perno, Carlo Federico
    Mengarelli, Andrea
    Arcese, William
    AMERICAN JOURNAL OF HEMATOLOGY, 2012, 87 (02) : 213 - 217
  • [39] Current practice in nutrition after allogeneic hematopoietic stem cell transplantation - Results from a survey among hematopoietic stem cell transplant centers
    Toenges, R.
    Greinix, H.
    Lawitschka, A.
    Halter, J.
    Baumgartner, A.
    Simon, A.
    Arends, J.
    Jaeger, P.
    Middeke, M.
    Hilgendorf, I.
    Klein, S.
    Wagner-Drouet, E. M.
    Schmid, C.
    Bug, G.
    Wolff, D.
    CLINICAL NUTRITION, 2021, 40 (04) : 1571 - 1577
  • [40] Management of dyslipidemia after allogeneic hematopoietic stem cell transplantation
    Yingxue Lu
    Xiaojing Ma
    Jie Pan
    Rongqiang Ma
    Yujie Jiang
    Lipids in Health and Disease, 21